The identification and enrichment of cancer stem cells have been described in various cancer models, and the methods most commonly involve the detection of specific cell-surface markers (e.g., CD133, CD44, CD24) and cytoplasmic proteins (e.g., aldehyde dehydrogenase, ALDH1) [16,17,18,19]. The gene discussed is CD44; the disease is cancer.